Skip to the page

Data / Form D filings / Tychon Biosciences LLC

Tychon Biosciences LLC: Form D filings

Tychon Biosciences LLC, a technology company in Minneapolis, MN, filed 2 Form D notices with the SEC between 2015 and 2018. The latest, on October 17, 2018, reports $200,000 sold of a $3 million offering to 2 investors.

Find out what Tychon Biosciences LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
807 Broadway Street NE, Suite 350, Minneapolis, MN, 55413
Phone
(612) 200-1039
Industry
Other Technology
Entity type
Limited Liability Company
Incorporated in
Delaware
Year incorporated
2014
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1659363

The full lists. Form D filings in Minnesota: 692 rows, $34.60, or the new rows each week for $19 a month. Form D filings in Other Technology: 8,166 rows, $161.66, or the new rows each week for $19.25 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 17, 2018New notice$3,000,000$200,000$2,800,0002Oct 9, 2018sec.gov
Nov 25, 2015New notice$3,000,000$470,736$2,529,2647Nov 2, 2015sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Charles J. Muscoplat, PhDExecutive Officer
Danny J. CunaginExecutive Officer, Director
Mark Z. SylvesterExecutive Officer
Arek Z. Dudek, MD PhDExecutive Officer
John Z. MacDonald, PhDExecutive Officer
Troy D. KopischkeExecutive Officer, Director

Other technology companies in Minnesota that filed recently

Every Form D from the week of Oct 15, 2018 · All recent filings in Minnesota · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Tychon Biosciences LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.